|
|
 |
|
Viewing report
|
|
|
|
India: Pharmaceutical
Internet Securities Inc, June 2008, Pages: 20
In 2006, India ranked 12th in the global pharmaceutical market in dollar terms with a market share of 1.27% globally. It was estimated that India’s pharmaceutical industry is worth USD 8.8 billion in 2005. Indian companies continue to dominate the generic market with a total market share of 70% in 2006. Meanwhile, India’s pharmaceutical industry accounted for approximately 21% of the global DMFs. India has 75 US FDA approved plants, the highest number of US FDA approved plants outside US.
Apart from the relatively low development cost and skilled manpower, the availability of raw materials at competitive prices makes India a preferred manufacturing hub for pharmaceutical giants. Another obvious reason is its IT prowess. As pharmacy research becoming more and more IT oriented, India is in a position to leverage on its strong IT base. India is also emerging as an important destination for global pharmaceutical companies, which are increasingly considering outsourcing and off shoring their drug discovery, research and development, and clinical research.
Customers who bought this item also bought
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
Understanding the Global Pharmaceutical Market
Indian Pharmaceutical Industry
Analyzing the Global Pharmaceutical Industry
Pharmaceutical Industry in the United States
Booming US Generic Drug Market
GenericHandbook - A Guide to the Generic Drug Industry in the US
Pharmaceutical Industry in India - PEST Framework Analysis
Booming Pharma Sector in India
The Indian Pharmaceutical Industry: Expansion & Ambitions
The Pharmaceutical Market: India
|
|
|
|
